Sequent Scientific Ltd.

NSE: SEQUENT | BSE: 512529 | ISIN: INE807F01027 |Industry: Pharmaceuticals
|Expensive Star
148.10 -1.40 (-0.94%)
NSE Oct 19, 2020 15:31 PM
Volume: 609.9K

Sequent Scientific Ltd.    
11 May 2020
Nirmal Bang Institutional
Carlyle to acquire Sequent Timing not right, impacts deal valuation Global investment firm The Carlyle Group (US$224bn AUM) has made an open offer of Rs86 per share to acquire majority stake (up to 74%) in Sequent Scientific. The open offer is triggered by its share purchase agreement (SPA) to acquire 44.9% equity stake from the promoter group at Rs86 per share. The cumulative holding of the promoter group stands at 56.15%. The residual promoter holding of 11.29% (not offered so far under SPA) is held by Mr. K. R. Ravishankar. This may also be available to Carlyle post closure of the open offer (assuming Carlyle does not reach the threshold of 74%). Carlyle has also signed a SPA with...
Sequent Scientific L.. has an average target of 146.33 from 3 brokers.
More from Sequent Scientific Ltd.